In 2017, an autologous chimeric antigen receptor (CAR) T cell therapy indicated for children
and young adults with relapsed and/or refractory CD19 + acute lymphoblastic leukaemia …

Acute myelogenous leukemia (AML) is a potentially curable disease; 70% of newly diagnosed
patients achieve complete remission with first-line therapy, but prognosis worsens for …

Background T cell mediated hyperinflammatory responses such as cytokine release syndrome
(CRS) and immune effector cell associated neurotoxicity syndrome (ICANS) are now well-…

Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication of
hematopoietic stem cell transplantation (HSCT). A single-center prospective screening study …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …

Simple Summary Pediatric patients with relapsed or refractory acute lymphoblastic leukemia
(ALL) or lymphoma (LBL) currently have unsatisfactory outcomes, and novel treatment …

Objective: To establish the current respiratory practice patterns in pediatric hematopoietic
stem cell transplant patients and investigate their associations with mortality across multiple …

Sinusoidal obstructive syndrome, also known as hepatic veno-occlusive disease, is a potentially
life-threatening complication that occurs in children undergoing haemopoietic stem-cell …

Combined advances in haematopoietic cell transplantation (HCT) and intensive care
management have improved the survival of patients with haematological malignancies admitted to …

Although T cell immune reconstitution after allogeneic hematopoietic stem cell transplantation
(allo-HSCT) has been well studied, long-term B cell immune reconstitution remains less …